TNF Pharmaceuticals, Inc. (NASDAQ:TNFA – Get Free Report) shares dropped 3.4% on Friday. The company traded as low as $0.4380 and last traded at $0.4404. 113,481 shares changed hands during trading, a decline of 100% from the average daily volume of 32,220,806 shares. The stock had previously closed at $0.4561.
TNF Pharmaceuticals Stock Performance
The firm has a fifty day simple moving average of $1.14 and a 200-day simple moving average of $3.10. The company has a market capitalization of $803,445.00, a PE ratio of -0.00 and a beta of 2.04.
TNF Pharmaceuticals Company Profile
TNF Pharmaceuticals, Inc is a biotechnology company focused on the development of therapies for diseases involving tumor necrosis factor (TNF), a protein associated with inflammation and immune-system activity.
The company’s research and development activities are centered on potential treatments for inflammatory and autoimmune conditions. Detailed information regarding its product pipeline, development stage, commercial operations, geographic reach and leadership is limited.
Further Reading
- Five stocks we like better than TNF Pharmaceuticals
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for TNF Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TNF Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
